TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Swedish Orphan Biovitrum AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,770
|
1,673
|
1,791 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
839
|
483
|
537 |
| Total assets |
3,666
|
2,797
|
2,557 |
| Current assets |
3,665
|
2,793
|
2,549 |
| Current liabilities |
729
|
357
|
378 |
| Equity capital |
2,938
|
2,440
|
2,179 |
| - share capital |
9
|
9
|
10 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
80.1%
|
87.2%
|
85.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
30.3%
|
28.9%
|
30.0% |
| Return on assets (ROA) |
22.9%
|
17.3%
|
21.0% |
| Current ratio |
502.7%
|
782.4%
|
674.3% |
| Return on equity (ROE) |
28.6%
|
19.8%
|
24.6% |
| Change turnover |
1,204
|
-24
|
-81 |
| Change turnover % |
77%
|
-1%
|
-4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.